IL201430A0 - Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep related breathing disorders - Google Patents

Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep related breathing disorders

Info

Publication number
IL201430A0
IL201430A0 IL201430A IL20143009A IL201430A0 IL 201430 A0 IL201430 A0 IL 201430A0 IL 201430 A IL201430 A IL 201430A IL 20143009 A IL20143009 A IL 20143009A IL 201430 A0 IL201430 A0 IL 201430A0
Authority
IL
Israel
Prior art keywords
desvenlafaxine
duloxetine
compositions
methods
treating sleep
Prior art date
Application number
IL201430A
Other languages
English (en)
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of IL201430A0 publication Critical patent/IL201430A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL201430A 2007-04-09 2009-10-11 Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep related breathing disorders IL201430A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92246607P 2007-04-09 2007-04-09
PCT/US2008/004508 WO2008124128A2 (en) 2007-04-09 2008-04-08 Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders

Publications (1)

Publication Number Publication Date
IL201430A0 true IL201430A0 (en) 2010-05-31

Family

ID=39831524

Family Applications (1)

Application Number Title Priority Date Filing Date
IL201430A IL201430A0 (en) 2007-04-09 2009-10-11 Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep related breathing disorders

Country Status (15)

Country Link
US (3) US20080293823A1 (enExample)
EP (2) EP2142183A2 (enExample)
JP (1) JP2010523662A (enExample)
KR (1) KR20100015923A (enExample)
CN (1) CN101686955A (enExample)
AR (1) AR065989A1 (enExample)
AU (1) AU2008236624A1 (enExample)
BR (1) BRPI0810159A2 (enExample)
CA (1) CA2683697C (enExample)
IL (1) IL201430A0 (enExample)
MX (1) MX2009010805A (enExample)
NZ (1) NZ580250A (enExample)
RU (1) RU2009141168A (enExample)
TW (1) TW200901956A (enExample)
WO (1) WO2008124128A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2521546A4 (en) * 2010-01-07 2013-06-26 Vivus Inc TREATMENT OF THE OBSTRUCTIVE SLEEP APNEO SYNDROME COMBINED WITH ANTIBODY ANTIBODY AND AN ADDITIONAL ACTIVE SUBSTANCE
WO2011155797A2 (ko) * 2010-06-10 2011-12-15 동아제약 주식회사 결정형 오-데스메틸벤라팍신의 헤미옥살레이트염, 그의 제조방법 및 그의 약제학적 조성물
CN111670050A (zh) 2018-01-30 2020-09-15 爱普宁公司(特拉华) 用于治疗睡眠呼吸暂停的方法和组合物
ES3049086T3 (en) * 2019-02-08 2025-12-12 Brigham & Womens Hospital Inc Methods and compositions for treating sleep apnea

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172896A (en) 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
US5803066A (en) * 1992-05-07 1998-09-08 New York University Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
GB9217295D0 (en) 1992-08-14 1992-09-30 Wellcome Found Controlled released tablets
US5541231A (en) 1993-07-30 1996-07-30 Glaxo Wellcome Inc. Stabilized Pharmaceutical
GB9315856D0 (en) 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US5358970A (en) 1993-08-12 1994-10-25 Burroughs Wellcome Co. Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
US6150396A (en) * 1997-03-07 2000-11-21 Eli Lilly And Company Methods of treating or preventing interstitial cystitis
AU2483599A (en) 1998-01-29 1999-08-16 Sepracor, Inc. Pharmaceutical uses of optically pure (-)-bupropion
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
CA2368083A1 (en) * 1999-04-06 2000-10-12 Sepracor Inc. Derivatives of venlafaxine and methods of preparing and using the same
AU5738700A (en) * 1999-06-15 2001-01-02 American Home Products Corporation Enantiomers of o-desmethyl venlafaxine
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
NZ548856A (en) * 2004-02-17 2009-10-30 Transcept Pharmaceuticals Inc Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
WO2006023703A2 (en) * 2004-08-20 2006-03-02 Cypress Bioscience, Inc. Method for treating sleep related breathing disorders
JP2008524332A (ja) * 2004-12-20 2008-07-10 コレジウム ファーマシューティカル， インク． 睡眠傷害のための医薬組成物
ES2423412T3 (es) * 2005-06-06 2013-09-20 The Board Of Trustees Of The University Of Illinois Composiciones y métodos para tratar los trastornos del sueño
WO2007026219A2 (en) * 2005-08-31 2007-03-08 Pfizer Products Inc. Combinations of a 5-ht1b antagonist with a noradrenalin re-uptake inhibitor or a serotonin noradrenalin reutake inhibitor for treating cns conditions
EP2500337A3 (en) * 2007-02-21 2012-12-26 Sepracor Inc. Solid form comprising (-) o-desmethylvenlafaxine and uses thereof
US20090048233A1 (en) * 2007-08-16 2009-02-19 Cypress Biosciences, Inc. Enhancing the Tolerability of a Seratonin Antagonist and a NSRI, a SNRI or a RIMA by Using Them in Combination

Also Published As

Publication number Publication date
NZ580250A (en) 2012-05-25
US20080293823A1 (en) 2008-11-27
AR065989A1 (es) 2009-07-15
JP2010523662A (ja) 2010-07-15
AU2008236624A1 (en) 2008-10-16
US20150196531A1 (en) 2015-07-16
KR20100015923A (ko) 2010-02-12
EP2455076A1 (en) 2012-05-23
CN101686955A (zh) 2010-03-31
CA2683697C (en) 2016-08-16
CA2683697A1 (en) 2008-10-16
WO2008124128A2 (en) 2008-10-16
WO2008124128A3 (en) 2009-05-07
EP2142183A2 (en) 2010-01-13
BRPI0810159A2 (pt) 2014-12-30
MX2009010805A (es) 2009-10-29
US20120238616A1 (en) 2012-09-20
TW200901956A (en) 2009-01-16
RU2009141168A (ru) 2011-05-20

Similar Documents

Publication Publication Date Title
EP2222359A4 (en) DEVICES AND METHOD FOR TREATMENT OF BREATHING IN SLEEP
EP2170309A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF DISEASES
EP2203206A4 (en) Methods and devices for treating sleep apnea
IL212079A0 (en) Methods and devices for treating sleep apnea
IL197001A0 (en) Combination treatment for metabolic disorders
IL202015A0 (en) Methods and compositions for treating skin conditions
GB2453188B (en) Use of compounds in the manufacture of medicaments for treatment of regional fat deposits
IL209032A0 (en) Compositions and methods for treating digestive disorders
IL188988A0 (en) Methods for preventing and treating metabolic disorders and new pyrazole-o-glycoside derivatives
LT2374472T (lt) Kompozicijos ir būdai oftalmologinių sutrikimų gydymui
SMT202300082T1 (it) Metodi e composizioni per il trattamento dei disturbi associati al complemento
EP2152266A4 (en) COMPOSITIONS AND METHODS OF TREATING DISORDERS RELATED TO SALT OR LIQUID RETENTION
EP2129683A4 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF HEART FAILURE AND OTHER DISORDERS
EP2349140A4 (en) DEVICES, SYSTEMS AND METHODS FOR TREATING SLEEP APNEA
IL197169A0 (en) Use of fgf-18 in the manufacture of a medicament for treatment of cartilage disorders
ZA201003497B (en) Methods for treating obesity and obesity related diseases and disorders
IL193936A0 (en) Compositions and methods for the treatment of immunoinflammatory disorders
PL2061501T3 (pl) Sposób leczenia zaburzeń oddechowych
IL194189A0 (en) Combination treatment of metabolic disorders
IL212707A0 (en) Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
GB2466912B (en) Compositions and methods for treating lysosomal disorders
EP2244690A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES AND DRESSES
IL198723A0 (en) Methods and compositions for therapeutic treatment
GB0909297D0 (en) Composition for the treatment of skin conditions
GB0718918D0 (en) Compositions and methods for treating skin conditions